Correlation Between Xilio Development and Lyra Therapeutics
Can any of the company-specific risk be diversified away by investing in both Xilio Development and Lyra Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xilio Development and Lyra Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Xilio Development and Lyra Therapeutics, you can compare the effects of market volatilities on Xilio Development and Lyra Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xilio Development with a short position of Lyra Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xilio Development and Lyra Therapeutics.
Diversification Opportunities for Xilio Development and Lyra Therapeutics
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Xilio and Lyra is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Xilio Development and Lyra Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lyra Therapeutics and Xilio Development is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xilio Development are associated (or correlated) with Lyra Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lyra Therapeutics has no effect on the direction of Xilio Development i.e., Xilio Development and Lyra Therapeutics go up and down completely randomly.
Pair Corralation between Xilio Development and Lyra Therapeutics
Considering the 90-day investment horizon Xilio Development is expected to generate 1.25 times more return on investment than Lyra Therapeutics. However, Xilio Development is 1.25 times more volatile than Lyra Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Lyra Therapeutics is currently generating about -0.09 per unit of risk. If you would invest 81.00 in Xilio Development on August 28, 2024 and sell it today you would earn a total of 7.00 from holding Xilio Development or generate 8.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Xilio Development vs. Lyra Therapeutics
Performance |
| Timeline |
| Xilio Development |
| Lyra Therapeutics |
Xilio Development and Lyra Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Xilio Development and Lyra Therapeutics
The main advantage of trading using opposite Xilio Development and Lyra Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xilio Development position performs unexpectedly, Lyra Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lyra Therapeutics will offset losses from the drop in Lyra Therapeutics' long position.| Xilio Development vs. Connect Biopharma Holdings | Xilio Development vs. Tyra Biosciences | Xilio Development vs. RAPT Therapeutics | Xilio Development vs. Mineralys Therapeutics, Common |
| Lyra Therapeutics vs. Eliem Therapeutics | Lyra Therapeutics vs. HCW Biologics | Lyra Therapeutics vs. Scpharmaceuticals | Lyra Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |